NCT00103792View on ClinicalTrials.gov

Mycophenolate Mofetil for Treatment of Relapses of Wegener's Disease or Microscopic Polyangiitis (MPA)

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

December 31, 2014

Study Completion Date

January 31, 2015

Conditions

Wegener's GranulomatosisVasculitis

Interventions

DRUG

mycophenolate mofetil

2000 mg mycophenolate mofetil per day combined with steroids for induction remission, followed by azathioprine standard maintenance therapy

DRUG

cyclophosphamide

2 mg/kg/d, combined with steroids, for remission induction, followed by standard azathioprine maintenance therapy

Trial Locations (1)

9700 RB

University Medical Centre Groningen, Groningen

All Listed Sponsors

lead

University Medical Center Groningen

OTHER

NCT00103792 - Mycophenolate Mofetil for Treatment of Relapses of Wegener's Disease or Microscopic Polyangiitis (MPA) | Biotech Hunter | Biotech Hunter